Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil

Clinical Rheumatology

Volumn 30, Issue 7, 2011, Pages 975-980

  Goeldner, Isabela ^a   Skare, Thelma L ^b   De Messias Reason, Iara T ^a   Nisihara, Renato M ^a   Silva, Marília B ^a   Da Rosa Utiyama, Shirley R ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b University Evangelic Hospital of Curitiba   (Brazil)

Author keywords

Anticyclic citrullinated peptide antibodies; Extra articular manifestations; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; ARTICLE; BRAZIL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL STATUS; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SEX DIFFERENCE; SMOKING; TOBACCO;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BRAZIL; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RHEUMATOID NODULE; SEX FACTORS; TOBACCO USE DISORDER;

EID: 79959595309     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1711-8     Document Type: Article

References (28)

1. Kvien T, Scherer HU, Burmester GR (2009) Rheumatoid arthritis. In: Bijlsma JWJ (ed) Eular compendium on rheumatic diseases. BMJ, Italy, pp 61-80
2. Van der Helm-van Mil AHM, Verpoort KN, Breedveld F, Toes REM, Huizinga T (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949-R958
3. Huizinga TW, Amos CI, Van der Helm-van Mil AHM, Chen W, van Gaalen FA, Jawaheer D et al (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of HLA-DR B1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52:3433-3438 (Pubitemid 41612209)
4. Klareskog L, Widhe M, Hermansson M, Rönnelid J (2008) Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr Opin Rheumatol 20:300-305 (Pubitemid 351483320)
5. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F et al (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11:R7
6. Silva AF, Matos AN, LimaAMS, Lima EF, Gaspar AP, Braga JAF et al (2006) Valor Diagnóstico do Anticorpo Antipeptídeo Citrulinado Cíclico na Artrite Reumatóide. Rev Bras Reumatol 46:174-180 (Pubitemid 46796902)
7. Mota LMH, Santos Neto LL, Burlingame R, Laurindo IMM (2009) Comportamento distinto dos sorotipos do fator reumatoide em avaliação seriada de pacientes com artrite reumatóide inicial. Rev Bras Reumatol 49:223-235
8. Jawaheer D, Lum RF, Gregersen PK, Criswell LA (2006) Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum 54:3087-3094 (Pubitemid 44622077)
9. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases - 2008. Isr Med Assoc J 10:13-19 (Pubitemid 351649456)
10. Onozaki K (2009) Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. Inflamm Allergy Drug Targets 8:364-368
11. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38-46 (Pubitemid 43122184)
12. Lee H-S, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H et al (2007) Interaction between smocking, the shared epitope and anti-cyclic citrullinated peptide. Arthritis Rheum 56:1745-1753
13. Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D et al (2008) Cigarette smoking, disease severity, and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 67:1529-1534
14. De Ricke L, Peene I, Hoffman IE, Kruithof E, Union A,Meheus L et al (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra articular manifestations. Ann Rheum Dis 63:1587-1593 (Pubitemid 39573686)
15. Korkmaz C, Us T, Kaşifoǧlu T, Akgün Y (2006) Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long standing rheumatoid arthritis and their relationship with extraarticular manifestations. Clin Biochem 39:961-965 (Pubitemid 44468211)
16. Kim S-K, Park S-H, Shin I-H, Choe J-Y (2008) Anti-cyclic citrullinated peptide antibody, smocking, alcohol consumption and disease duration as risk factors for extra-articular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol 35:995-1001 (Pubitemid 351813143)
17. Turesson C, Jakobson LTH (2005) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65-72
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324 (Pubitemid 18091653)
19. Daniel T (2008) Sjögren's syndrome. In: Klippel JH, Stone JH, Crofford LJ, White PH (eds) Primer on rheumatic diseases. Springer, New York, pp 389-397
20. Klippel JH, Dieppe PA (1998) Selected measures for outcome assessment of rheumatic diseases. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, pp S-A:1-S-A:12
21. Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P et al (2008) Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 67:466-470 (Pubitemid 351498425)
22. MacKay J, Crofton J (1996) Tobacco and the developing world. In: Doll R, Crofton J (eds) Tobacco and health. Royal Society of Medicine, London
23. Skare TL, Silva MBG, Silva MG, Gomes F, Rumor C, Giacomini G (2002) Rheumatoid factor and tobacco exposure. Braz Arch Biol Technol 45:203-207
24. Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH (2009) Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 68:201-208
25. Manavalan JS, Kirman I, Zhao K, Weksler ME (1998) Aging and autoimmunity. In: Rose NR, Mackay IR (eds) The autoimmune diseases. Academic, San Diego, pp 783-794
26. Cimmino MA, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia MT (2000) Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 19:213-217
27. Martinéz-Castro E, Olivé Marqués A, Bonet Llorach M, Carbonell Abeló J, Cobo Valeri E, Juncà Valdor S (1990) Rheumatoid arthritis and Sjögren syndrome: special reference to the course time of rheumatoid arthritis. Med Clin Barc 94:655-659
28. Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Clin Lab Sci 21:15-18